106 related articles for article (PubMed ID: 1564024)
1. Growth deficits in children treated with desipramine: a controlled study.
Spencer T; Biederman J; Wright V; Danon M
J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):235-43. PubMed ID: 1564024
[TBL] [Abstract][Full Text] [Related]
2. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.
Schertz M; Adesman AR; Alfieri NE; Bienkowski RS
Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958
[TBL] [Abstract][Full Text] [Related]
3. Effect of stimulants on height and weight: a review of the literature.
Faraone SV; Biederman J; Morley CP; Spencer TJ
J Am Acad Child Adolesc Psychiatry; 2008 Sep; 47(9):994-1009. PubMed ID: 18580502
[TBL] [Abstract][Full Text] [Related]
4. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?
Spencer TJ; Biederman J; Harding M; O'Donnell D; Faraone SV; Wilens TE
J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1460-9. PubMed ID: 8936912
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.
Moungnoi P; Maipang P
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770
[TBL] [Abstract][Full Text] [Related]
6. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
[TBL] [Abstract][Full Text] [Related]
7. Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD.
Zhang H; Du M; Zhuang S
Neuropediatrics; 2010 Aug; 41(2):55-9. PubMed ID: 20799150
[TBL] [Abstract][Full Text] [Related]
8. Side effects of methylphenidate and desipramine alone and in combination in children.
Pataki CS; Carlson GA; Kelly KL; Rapport MD; Biancaniello TM
J Am Acad Child Adolesc Psychiatry; 1993 Sep; 32(5):1065-72. PubMed ID: 8407753
[TBL] [Abstract][Full Text] [Related]
9. Weight, Height, and Body Mass Index in Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate.
Díez-Suárez A; Vallejo-Valdivielso M; Marín-Méndez JJ; de Castro-Manglano P; Soutullo CA
J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):723-730. PubMed ID: 28817309
[TBL] [Abstract][Full Text] [Related]
10. A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy.
Biederman J; Baldessarini RJ; Wright V; Knee D; Harmatz JS
J Am Acad Child Adolesc Psychiatry; 1989 Sep; 28(5):777-84. PubMed ID: 2676967
[TBL] [Abstract][Full Text] [Related]
11. ADHD and growth: anthropometric changes in medicated and non-medicated ADHD boys.
Ptacek R; Kuzelova H; Paclt I; Zukov I; Fischer S
Med Sci Monit; 2009 Dec; 15(12):CR595-9. PubMed ID: 19946228
[TBL] [Abstract][Full Text] [Related]
12. Effects of osmotic-release methylphenidate on height and weight in children with attention-deficit hyperactivity disorder (ADHD) following up to four years of treatment.
Durá-Travé T; Yoldi-Petri ME; Gallinas-Victoriano F; Zardoya-Santos P
J Child Neurol; 2012 May; 27(5):604-9. PubMed ID: 22190507
[TBL] [Abstract][Full Text] [Related]
13. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
Marcus SC; Wan GJ; Kemner JE; Olfson M
Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
[TBL] [Abstract][Full Text] [Related]
14. Ten years of experience with 1,000 hyperactive children in a private practice.
Eichlseder W
Pediatrics; 1985 Aug; 76(2):176-84. PubMed ID: 4022690
[TBL] [Abstract][Full Text] [Related]
15. Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children?
Sund AM; Zeiner P
Nord J Psychiatry; 2002; 56(1):53-7. PubMed ID: 11869467
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term psychostimulant medication on growth of children with ADHD.
Zachor DA; Roberts AW; Hodgens JB; Isaacs JS; Merrick J
Res Dev Disabil; 2006; 27(2):162-74. PubMed ID: 15955659
[TBL] [Abstract][Full Text] [Related]
17. Growth in stimulant-naive children with attention-deficit/hyperactivity disorder using cross-sectional and longitudinal approaches.
Hanć T; Cieślik J
Pediatrics; 2008 Apr; 121(4):e967-74. PubMed ID: 18381524
[TBL] [Abstract][Full Text] [Related]
18. Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder.
Fitzpatrick PA; Klorman R; Brumaghim JT; Borgstedt AD
J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):226-34. PubMed ID: 1564023
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder.
Hammerness P; Wilens T; Mick E; Spencer T; Doyle R; McCreary M; Becker J; Biederman J
J Pediatr; 2009 Jul; 155(1):84-9, 89.e1. PubMed ID: 19394037
[TBL] [Abstract][Full Text] [Related]
20. Growth and sexual maturation in children and adolescents with attention deficit hyperactivity disorder.
Poulton A
Curr Opin Pediatr; 2006 Aug; 18(4):427-34. PubMed ID: 16914999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
